Serological Assays for the Detection and Characterization of Influenza Viruses
75D30125R73235 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Atlanta, GA, with responses due 2025-02-07. AwardCast estimates what this specific solicitation will close for, before you bid.
75D30125R73235
solicitation
325413
NAICS
Q301
PSC
Not set aside
set-aside
Atlanta, GA
place
2025-02-07
responses due
What's being bought
The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay. This is Phase I of a a two phased multi-step mandatory down
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| WERFEN USA LLC | $18K | 1 | 2024-09-30 |
| ORTHO-CLINICAL DIAGNOSTICS GMBH | $4K | 2 | 2024-09-30 |
| HOLOGIC, INC. | $1.2M | n/a | 2024-09-30 |
| LUMINEX CORP | $89K | 1 | 2024-09-30 |
| PHADIA US INC | $13.8M | n/a | 2024-09-30 |
Explore the market
Comparable awards ran from $4K to $13.8M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.